These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 6345130)

  • 21. Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs.
    Brater DC
    Am J Med; 1986 Jan; 80(1A):62-77. PubMed ID: 3511686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the protein-binding on the mode of drug action as well the interactions with other drugs.
    Tesseromatis C; Alevizou A
    Eur J Drug Metab Pharmacokinet; 2008; 33(4):225-30. PubMed ID: 19230595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma protein binding of drugs in pregnancy and in neonates.
    Notarianni LJ
    Clin Pharmacokinet; 1990 Jan; 18(1):20-36. PubMed ID: 2178848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics.
    McNamara PJ; Slattery JT; Gibaldi M; Levy G
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):397-405. PubMed ID: 512845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function.
    Reidenberg MM
    Am J Med; 1977 Apr; 62(4):466-70. PubMed ID: 851114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.
    Miners JO
    Clin Pharmacokinet; 1989 Nov; 17(5):327-44. PubMed ID: 2573442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.
    Tillement JP; Albengres E; Urien S
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):123-7. PubMed ID: 393513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.
    Palatini P; Orlando R; De Martin S
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1215-30. PubMed ID: 20604736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On representation and interpretation of drug displacement interactions [proceedings].
    Aarons LJ; Schary WL; Rowland M
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():2P. PubMed ID: 22648
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
    Logan R; Funk RS; Axcell E; Krise JP
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug displacement from protein binding: isolation of a redistributional drug interaction in vivo.
    McQueen EG; Wardell WM
    Br J Pharmacol; 1971 Oct; 43(2):312-24. PubMed ID: 5158200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and tissue binding considerations in drug disposition.
    Wilkinson GR
    Drug Metab Rev; 1983; 14(3):427-65. PubMed ID: 6347593
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of unbound volumes of drug distribution in pharmacokinetic calculations.
    Stepensky D
    Eur J Pharm Sci; 2011 Jan; 42(1-2):91-8. PubMed ID: 21050885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for monitoring free drug levels.
    Levy RH; Moreland TA
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of drug binding, protein binding, and binding displacement drug interactions.
    DeVane CL
    Psychopharmacol Bull; 2002; 36(3):5-21. PubMed ID: 12473961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive binding of bilirubin and drugs to human serum albumin studied by enzymatic oxidation.
    Brodersen R
    J Clin Invest; 1974 Dec; 54(6):1353-64. PubMed ID: 4436437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.
    Verbeeck RK
    Clin Pharmacokinet; 1990 Jul; 19(1):44-66. PubMed ID: 2199127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Capacity limited pharmacokinetics, a mechanism of drug toxicity (author's transl)].
    Dettli L
    Arzneimittelforschung; 1977; 27(96):1844-8. PubMed ID: 579151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of plasma protein binding displacement and its implications for quantitative assessment of metabolic drug-drug interactions from in vitro data.
    Christensen H; Baker M; Tucker GT; Rostami-Hodjegan A
    J Pharm Sci; 2006 Dec; 95(12):2778-87. PubMed ID: 16937340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.